Inari Medical

Today at #TCT, Dr. Wissam A Jaber (Co-PI) presented results from the #PEERLESS RCT. As the first major pulmonary embolism RCT in a decade—and the first ever to evaluate thrombectomy—PEERLESS marks a pivotal advancement in PE care, setting a new standard for the field. More: https://bit.ly/PEERLESS Carin Gonsalves Cardiovascular Research Foundation

Join us this weekend at #TheVEINS24 to hear Drs. Andrew Niekamp, David Dexter, and Samuel Horr discuss how Inari's commitment to clinical evidence is changing the paradigm of venous disease. Visit us this Saturday, November 2 and Sunday, November 3 at Booth #13 to learn more! #InariMedical #TheVEINS24 #MedicalInnovation The VIVA Foundation #PEERLESS #CLOUT

ICYMI: #PEERLESS RCT results show a clear win for FlowTriever over CDT on the 5-component win ratio primary endpoint. Patients experienced: - 3X fewer deteriorations and/or therapy escalations - Better, faster recovery of symptoms and hemodynamics - Less ICU utilization, hospital LOS, and readmission burden. Join us next week for our #ClotWarriorAcademy webinar to learn more! Register here: https://bit.ly/4hssYED

"I had a pulmonary embolism. The biggest my ER doctor had ever seen. It tried to end my life but thanks to Inari and a team of highly skilled physicians, I'm still here. And because of that, I have a totally different outlook on life and I plan on living it to the max until I'm not here anymore." - Steve What would you do if you were gifted a second chance at life? For Steve, experiencing a pulmonary embolism changed his life forever. Steve’s path to recovery is a powerful reminder of resilience and medical innovation. Learn more about the FlowTriever System at: https://bit.ly/4dHrsfk

7 days until our next #ClotWarriorAcademy webinar! We’ll discuss how #FlowTriever thrombectomy compares to CDT in treating intermediate-risk PE patients, delve into practical implications for PE intervention strategies, and review case examples highlighting intervention selection and outcomes. Register here: https://bit.ly/4hssYED

Calling all residents and fellows! Don't miss out on an exciting opportunity next Monday, November 4th, at #VIVA24. Join our Medical Affairs team, Drs. Andrew Niekamp and Adam Gwozdz and expert faculty, Dr. Steven Abramowitz for networking and hands-on experience with the latest #VTE technology. This is your chance to connect, learn, and elevate your skills. We can't wait to meet you! #InariMedical #MedicalInnovation

Earlier this week, we announced strong Q3 2024 financial results including record revenue of $153 million, up 21%. We also released results from our PEERLESS RCT which showed superiority of FlowTriever compared to catheter-directed thrombolytics for intermediate-risk pulmonary embolism. Lastly, our next-generation Artix system for arterial thrombectomy recently entered limited market release. Taken together, we're looking forward to a strong finish to 2024. More: https://bit.ly/3C53ehv

What a week at #TCT2024! Thank you to everyone who joined us at the booth and those who listened in as Dr. Wissam A Jaber presented the positive results from the #PEERLESS RCT during the Late-Breaking Clinical Trial Session! We appreciated the insights shared by Drs. Wissam A Jaber, Jay Giri, Samuel Horr, MD, Sripal Bangalore, and Thomas Tu, MD during The Clinical PE Story: "PEERLESS RCT Comparing #FlowTriever to CDT." PEERLESS represents a significant advancement in PE care and sets a new standard in the field. We value your engagement and look forward to continuing our work in advancing patient care together! Learn more about PEERLESS: https://bit.ly/PEERLESS